MSK Named One of Becker's '100 Great Hospitals' for 2025

This is something every MSK employee can be proud of.

Memorial Sloan Kettering Cancer Center (MSK) was named one of Becker’s Hospital Review’s 2025 “100 Great Hospitals in America.” This national honor is given to hospitals that provide excellent care, keep patients safe, and lead in research, learning, and new ideas.

Hospitals on this list are also often recognized by trusted groups like U.S. News & World Report, Healthgrades, CMS, and The Leapfrog Group. Hospitals cannot pay to be on this list—it is earned through real results and independent review.

 

This recognition reflects the work MSK employees do every day to turn research into care that helps patients live longer and better lives.

Some recent examples include:
• Breakthrough research: MSK led important cancer studies in 2024–2025, including a rectal cancer trial where every patient responded to treatment.• Innovation for the future: MSK opened the Olayan Center for Cancer Vaccines to support new discoveries.
• Wide-ranging advances: Teams continue to make progress in immunotherapy, cancer vaccines, CAR T-cell therapy, and AI tools.
• Access to care: MSK runs more than 1,800 clinical trials and helps about 5,000 patients each year from around the world.
• Real impact: MSK helped develop over 40 FDA-approved cancer treatments in the past five years.

This honor belongs to MSK employees—the doctors, nurses, researchers, and staff—whose dedication and teamwork make MSK a world leader in cancer care.